Cargando…

Evaluation of epicardial adipose tissue in familial partial lipodystrophy

BACKGROUND: Dunnigan type Familial Partial Lipodystrophy (FPLD) is characterized by loss of subcutaneous fat from the limbs and excessive accumulation on the visceral adipose tissue (VAT). Affected individuals have insulin resistance (IR), diabetes, dyslipidemia and early cardiovascular (CV) events,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godoy-Matos, Amélio Fernando, Valério, Cynthia M, Bragança, Juliana Bonadiman e, Oliveira, Ricardo de Andrade, Zagury, Roberto Luis, Lustosa, Rodolfo de Paula, Camargo, Gabriel Cordeiro, Nascimento, César Augusto da Silva, Moreira, Rodrigo O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391299/ https://www.ncbi.nlm.nih.gov/pubmed/25859279 http://dx.doi.org/10.1186/s13098-015-0024-5

Ejemplares similares

Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2
por: Valerio, Cynthia Melissa, et al.
Publicado: (2017)

Pancreatic fat deposition is increased and related to beta-cell function in women with familial partial lipodystrophy
por: Godoy-Matos, Amelio F., et al.
Publicado: (2018)

Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women
por: Viola, Luiz F., et al.
Publicado: (2023)

Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation
por: Valerio, Cynthia M, et al.
Publicado: (2012)

Erratum: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation
por: Valerio, Cynthia M, et al.
Publicado: (2015)

Type 2 Diabetes With Partial Lipodystrophy of the Limbs: A new lipodystrophy phenotype
por: Strickland, Leah R., et al.
Publicado: (2013)

Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias, Christos, et al.
Publicado: (2020)

Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy
por: Domingo, Pere, et al.
Publicado: (2022)

Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
por: Chiquette, Elaine, et al.
Publicado: (2017)

SUN-556 Cardiac Phenotype in Familial Partial Lipodystrophy
por: Eldin, Abdelwahab Jalal, et al.
Publicado: (2020)

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
por: Godoy-Matos, Amélio F., et al.
Publicado: (2020)

A Single Complex Agpat2 Allele in a Patient With Partial Lipodystrophy
por: Broekema, Marjoleine F., et al.
Publicado: (2018)

Recurrent stroke as a presenting feature of acquired partial lipodystrophy
por: Prasad, Namburi R., et al.
Publicado: (2012)

Adult-Onset Acquired Partial Lipodystrophy Accompanied by Rheumatoid Arthritis
por: Muto, Yusuke, et al.
Publicado: (2015)

Bleomycin Containing Chemotherapeutic Regimen Induced Acquired Partial Lipodystrophy
por: Tandon, Vishal R, et al.
Publicado: (2016)

Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
por: Jéru, Isabelle, et al.
Publicado: (2019)

Partial Lipodystrophy and LMNA p.R545H Variant
por: Magno, Silvia, et al.
Publicado: (2021)

Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain
por: Fernández-Pombo, Antía, et al.
Publicado: (2023)

PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function
por: Bruder-Nascimento, Thiago, et al.
Publicado: (2019)

Evaluation of the hypothalamic–pituitary–adrenal axis in a case series of familial partial lipodystrophy
por: Elias, Cecília Pacheco, et al.
Publicado: (2019)

Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome
por: Donadille, Bruno, et al.
Publicado: (2013)

Iron parameters in patients with partial lipodystrophy and impact of exogenous leptin therapy
por: Akinci, Efe Y, et al.
Publicado: (2021)

Familial Partial Lipodystrophy: A Case Study and Review of Recent Literature
por: Tipu, Ali, et al.
Publicado: (2021)

Targeted Therapeutic Approach in Patients With Familial Partial Lipodystrophy Type 3
por: Cohen, Benjamin, et al.
Publicado: (2021)

OR17-02 Changes in Hepatokines and Apolipoproteins Are Associated with Metabolic Response to Metreleptin in Partial Lipodystrophy
por: Akinci, Baris, et al.
Publicado: (2020)

Inhibition of Angiopoietin-Like 3 (ANGPTL3) Reduces Adipose Tissue Insulin Resistance in Patients With Familial Partial Lipodystrophy
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis
por: Cook, Keziah, et al.
Publicado: (2021)

Familial partial lipodystrophy type 2 and obesity, two adipose tissue pathologies with different inflammatory profiles
por: Treiber, Guillaume, et al.
Publicado: (2023)

Clinical Characteristics, Phenotype of Lipodystrophy and a Genetic Analysis of Six Diabetic Japanese Women with Familial Partial Lipodystrophy in a Diabetic Outpatient Clinic
por: Iwanishi, Masanori, et al.
Publicado: (2018)

Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type
por: Foss-Freitas, Maria C., et al.
Publicado: (2018)

An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease
por: Panikkath, Ragesh, et al.
Publicado: (2016)

SUN-607 Iron Parameters in Patients with Partial Lipodystrophy and Impact of Metreleptin Therapy
por: Boutros, Sabine, et al.
Publicado: (2020)

Novel Heterozygous LMNA Variants Causing Familial Partial Lipodystrophy, Dunnigan Variety
por: Wadhwa, Akhilesh, et al.
Publicado: (2021)

Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2022)

FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
por: Agarwal, Shubham, et al.
Publicado: (2023)

The acromegaly lipodystrophy
por: Freda, Pamela U.
Publicado: (2022)

Cardiac Alterations in Patients with Familial Lipodystrophy
por: Romano, Minna Moreira Dias, et al.
Publicado: (2020)

Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer–Simons syndrome)
por: Corvillo, Fernando, et al.
Publicado: (2021)

Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy
por: Cândido Dantas, Verônica Kristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lnuqqqi6cnds2es64i3ma6f9ne